Evidence map›Paper›PMID 28072767›Full record

ArticleBritish journal of cancer2017

CYP3A7*1C allele is associated with reduced levels of 2-hydroxylation pathway oestrogen metabolites.

Deepti Sood, Nichola Johnson, Pooja Jain, Alexandros P Siskos, Mark Bennett, Clare Gilham, Marta Cecilia Busana, Julian Peto, Isabel Dos-Santos-Silva, Hector C Keun and 1 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Deepti SoodFaculty of Medicine, Department of Surgery and Cancer, Imperial College, London SW7 2AZ, UK.
Nichola JohnsonBreast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, 237 Fulham Road, London SW7 3RP, UK.
Pooja JainFaculty of Medicine, Department of Surgery and Cancer, Imperial College, London SW7 2AZ, UK.
Alexandros P SiskosFaculty of Medicine, Department of Surgery and Cancer, Imperial College, London SW7 2AZ, UK.
Mark BennettDepartment of Life Sciences, Imperial College, London SW7 2AZ, UK.
Clare GilhamDepartment of Non-Communicable Disease Epidemiology, The London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Marta Cecilia BusanaDepartment of Non-Communicable Disease Epidemiology, The London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Julian PetoDepartment of Non-Communicable Disease Epidemiology, The London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Isabel Dos-Santos-SilvaDepartment of Non-Communicable Disease Epidemiology, The London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Hector C KeunFaculty of Medicine, Department of Surgery and Cancer, Imperial College, London SW7 2AZ, UK.
Olivia FletcherBreast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, 237 Fulham Road, London SW7 3RP, UK.
Imperial College London · GBInstitute of Cancer Research · GBLondon School of Hygiene & Tropical Medicine · GBUniversity of London · GB

Funding

Cancer Research UK C1178/A10292Cancer Research UK C405/A14565Cancer Research UK C405/A2144
6 · The paper itself

Abstract

backgroundEndogenous sex hormones are well-established risk factors for breast cancer; the contribution of specific oestrogen metabolites (EMs) and/or ratios of specific EMs is less clear. We have previously identified a CYP3A7*1C allele that is associated with lower urinary oestrone (E

methodsWe measured successfully 12 EMs in mid-follicular phase urine samples from 30 CYP3A7*1C carriers and 30 non-carriers using HPLC-MS/MS.

resultsIn addition to having lower urinary E

conclusionsThe CYP3A7*1C allele is associated with a lower urinary E

Indexed as

PremenopauseAdolescentAdultAllelesBreast NeoplasmsCytochrome P-450 CYP3ADown-RegulationEstrogensEstroneFemaleGenetic Carrier ScreeningHumansHydroxylationMetabolic Networks and PathwaysMiddle AgedRisk FactorsCYP3A7 protein, humanCytochrome P-450 CYP3AEstrogensEstrone

Identifiers

PMID28072767
PMCPMC5294487
OpenAlexW2570612638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.